FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Iman Jilani

Research Profile

Procedures

Flow Cytometry

Disorders

Concepts & Ideas

Survival Rate

Chemicals & Drugs

Physiology

Mutation

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Maher Albitar; Steven Potts; Francis Giles; Susan O'Brien; Iman Jilani; Amber C Donahue; Elihu H Estey; Andrew Lamb
Proteomics-based prediction of clinical response in acute myeloid leukemia.
Iman Jilani; C Wei; B N Bekele; Z J Zhang; M Keating; W Wierda; Alessandra Ferrajoli; Zeev Estrov; Andrew Lamb; S M O'Brien; Francis Giles; Maher Albitar
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
Iman Jilani; Andrew Lamb; Homan Faraji; Mercedes Gorre; Jorge Cortes; Oliver G Ottmann; Kapil N Bhalla; Susan O'Brien; Francis Giles; Maher Albitar
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Iman Jilani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Maher Albitar; Steven Potts; Francis Giles; Susan O'Brien; Iman Jilani; Amber C Donahue; Elihu H Estey; Andrew Lamb
Proteomics-based prediction of clinical response in acute myeloid leukemia.
Experimental hematology 2009;37(7):784-90.
2009: Iman Jilani; C Wei; B N Bekele; Z J Zhang; M Keating; W Wierda; Alessandra Ferrajoli; Zeev Estrov; Andrew Lamb; S M O'Brien; Francis Giles; Maher Albitar
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
International journal of laboratory hematology 2009;31(1):97-105.
2008: Iman Jilani; Andrew Lamb; Homan Faraji; Mercedes Gorre; Jorge Cortes; Oliver G Ottmann; Kapil N Bhalla; Susan O'Brien; Francis Giles; Maher Albitar
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.
Leukemia research 2008;32(6):936-43.
2008: Wanlong Ma; Andrew Lamb; Xi Zhang; Weimin Sun; Arlene M Buller; Iman Jilani; Joyce G Schwartz; Francis Giles; Maher Albitar
Higher detection rate of JAK2 mutation using plasma.
Blood 2008;111(7):3906-7.
2008: Iman Jilani; Andrew Lamb; Mercedes Gorre; Jorge Cortes; Oliver G Ottmann; Kapil N Bhalla; Francis Giles; Maher Albitar
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
Leukemia research 2008;32(4):643-9.
2008: Wanlong Ma; Andrew Lamb; Susan O'Brien; Iman Jilani; Xi Zhang; Zeev Estrov; Alessandra Ferrajoli; Michael Keating; Francis Giles; Maher Albitar
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
Cancer 2008;112(6):1306-12.
2007: Joanne Bareng; Iman Jilani; Mercedes Gorre; Andrew Lamb; Francis Giles; Alison Hannah; Maher Albitar
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry.
Leukemia & lymphoma 2007;48(11):2189-95.
2007: Farhad Ravandi; Iman Jilani; Elihu Estey; Andrew Lamb; A Dey; C Aguilar; C Jitkaroon; Francis Giles; Susan O'Brien; Michael Keating; Maher Albitar
Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
Leukemia research 2007;31(6):791-7.
2007: Maher Albitar; M Johnson; Kim-Anh Do; A Day; Iman Jilani; S Pierce; E Estey; H Kantarjian; M Keating; S Verstovsek; S O'brien; Francis Giles
Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Leukemia 2007;21(3):480-8.
2007: Wanlong Ma; Richard Tseng; Mercedes Gorre; Iman Jilani; Michael Keating; Andrew Lamb; Jorge Cortes; Susan O'Brien; Francis Giles; Maher Albitar
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia.
Haematologica 2007;92(2):170-5.
2007: Maher Albitar; Julie M Vose; Marcella M Johnson; Kim-Anh Do; Amanda Day; Iman Jilani; Andrew Lamb; Michael Keating; Susan M O'Brien; Srdan Verstovsek; James O Armitage; Francis Giles
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Leukemia research 2007;31(2):139-45.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Detection of chromosome translocations by bead-based flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():167-74.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Measuring humanized antibodies in plasma of patients treated with antibody-based therapy using bead-based flow cytometry: the story of alemtuzumab.
Methods in molecular biology (Clifton, N.J.) 2007;378():159-65.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Cell-free bead-based detection of total and phosphorylated proteins in plasma and cell lysates: detection of FLT3.
Methods in molecular biology (Clifton, N.J.) 2007;378():153-7.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Monitoring cell signaling pathways by quantitative flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():83-90.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Quantification of surface antigens and quantitative flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():65-9.
2007: Mohammad Sheikholeslami; Iman Jilani; Maher Albitar
He use of the antibodies in the diagnosis of leukemia and lymphoma by flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():53-63.
2006: W Ma; Andrew Lamb; Iman Jilani; Mercedes Gorre; Kapil N Bhalla; Oliver G Ottmann; Francis Giles; Maher Albitar
Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA.
Leukemia 2006;20(11):1989-91.
2006: Iman Jilani; M Keating; A Day; W William; Andrew Lamb; S O'brien; Francis Giles; Maher Albitar
Simplified sensitive method for the detection of B-cell clonality in lymphoid malignancies.
Clinical and laboratory haematology 2006;28(5):325-31.
2006: W Ma; Andrew Lamb; Srdan Verstovsek; Iman Jilani; Mercedes Gorre; Francis Giles; J Cortes; S O'Brien; M Keating; Maher Albitar
Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour.
British journal of haematology 2006;134(3):341-3.
2006: Charles Koller; B Nebiyou Bekele; Xian Zhou; Charles Park; Zeev Estrov; Susan O'Brien; Michael Keating; Iman Jilani; Francis Giles; Hagop M Kantarjian; Maher Albitar
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia.
Blood 2006;108(3):1001-6.
2006: W Ma; Iman Jilani; Mercedes Gorre; M Keating; H Chan; R Tseng; Andrew Lamb; S O'Brien; Francis Giles; Maher Albitar
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia.
British journal of haematology 2006;133(6):690-2.
2006: Maher Albitar; Steven Potts; Francis Giles; Susan O'Brien; Michael Keating; Deborah Thomas; Charlotte Clarke; Iman Jilani; Christine Aguilar; Elihu Estey; Andrew Lamb
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
Cancer 2006;106(7):1587-94.
2005: Stefan Faderl; Kim-Anh Do; Marcella M Johnson; Michael Keating; Susan O'Brien; Iman Jilani; Alessandra Ferrajoli; Farhad Ravandi-Kashani; Christine Aguilar; Amanda Dey; Deborah A Thomas; Francis Giles; Hagop M Kantarjian; Maher Albitar
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
Blood 2005;106(13):4303-7.
2005: Hesham M Amin; Y Yang; Yu Shen; Elihu H Estey; Francis Giles; Sherry A Pierce; Hagop M Kantarjian; Susan M O'Brien; Iman Jilani; Maher Albitar
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
Leukemia 2005;19(9):1567-72.
2004: Iman Jilani; Michael Keating; Francis Giles; Susan O'Brien; Hagop M Kantarjian; Maher Albitar
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay.
Leukemia research 2004;28(12):1255-62.
2004: Maher Albitar; Kim-Anh Do; Marcella M Johnson; Francis Giles; Iman Jilani; Susan O'Brien; Jorge Cortes; Deborah Thomas; Laura Rassenti; Thomas Kipps; Hagop M Kantarjian; Michael Keating
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies.
Cancer 2004;101(5):999-1008.
2004: Qinglong Hu; Amanda L Dey; Ying Yang; Yu Shen; Iman Jilani; Elihu H Estey; Hagop M Kantarjian; Francis Giles; Maher Albitar
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
Cancer 2004;100(9):1884-91.
2004: Anna Rogers; Youngson Joe; Taghi Manshouri; Amanda Dey; Iman Jilani; Francis Giles; Elihu Estey; Emil J Freireich; Michael Keating; Andrew Lamb; Maher Albitar
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.
Blood 2004;103(7):2799-801.
2003: Iman Jilani; Susan O'Brien; Taghi Manshuri; Deborah A Thomas; Vilmos A Thomazy; Maha Imam; Sana Naeem; Srdan Verstovsek; Andrew Lamb; Francis Giles; Michael Keating; Maher Albitar
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia.
Blood 2003;102(10):3514-20.
2003: Maha Ahmed; Francis Giles; Youngson Joe; Donna M Weber; Iman Jilani; Taghi Manshouri; Sergio Giralt; Marcos De Lima; Michael Keating; Maher Albitar
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
European journal of haematology 2003;71(3):174-8.
2003: Hesham M Amin; Iman Jilani; Elihu H Estey; Michael J Keating; Amanda L Dey; Taghi Manshouri; Hagop M Kantarjian; Zeev Estrov; Jorge E Cortes; Deborah A Thomas; Francis Giles; Maher Albitar
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome.
Blood 2003;102(5):1866-8.
2003: Hatice Duzkale; Iman Jilani; Nada Orsolic; Ralph A Zingaro; Mirna Golemovic; Francis Giles; Andrew Lamb; Maher Albitar; Emil J Freireich; Srdan Verstovsek
In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.
Cancer chemotherapy and pharmacology 2003;51(5):427-32.
2003: Sherif Ibrahim; Iman Jilani; Susan O'Brien; Anna Rogers; Taghi Manshouri; Francis Giles; Stefan Faderl; Deborah Thomas; Andrew Lamb; Michael Keating; Maher Albitar
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Cancer 2003;97(8):1914-9.
2003: Taghi Manshouri; Kim-Anh Do; Xuemei Wang; Francis Giles; Susan M O'Brien; Helene Saffer; Deborah Thomas; Iman Jilani; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.
Blood 2003;101(7):2507-13.
2003: Iman Jilani; Elihu Estey; T Manshuri; M Caligiuri; Michael Keating; Francis Giles; Deborah Thomas; Andrew Lamb; Maher Albitar
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Leukemia 2003;17(1):114-9.
2002: Yang O Huh; Iman Jilani; Elihu Estey; Francis Giles; Andrew Lamb; Emil J Freireich; Maher Albitar
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Leukemia 2002;16(11):2249-52.
2002: Iman Jilani; Elihu Estey; Yang Huh; Youngson Joe; Taghi Manshouri; Marwan Yared; Francis Giles; Andrew Lamb; Jorge Cortes; Deborah Thomas; Michael Keating; Emil J Freireich; Maher Albitar
Differences in CD33 intensity between various myeloid neoplasms.
American journal of clinical pathology 2002;118(4):560-6.
2002: LaBaron T Washington; Iman Jilani; Elihu Estey; Maher Albitar
Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia.
Leukemia research 2002;26(10):899-902.
2002: Naoko Ishibe; Maher Albitar; Iman Jilani; Lynn R Goldin; Gerald E Marti; Neil E Caporaso
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
Blood 2002;100(3):1100-1.
2002: Maher Albitar; Taghi Manshouri; Yu Shen; Diane Liu; Miloslav Beran; Hagop M Kantarjian; Anna Rogers; Iman Jilani; Chung-Wu Lin; Sherry Pierce; Emil J Freireich; Elihu H Estey
Myelodysplastic syndrome is not merely "preleukemia".
Blood 2002;100(3):791-8.
2002: Chung-Wu Lin; Taghi Manshouri; Iman Jilani; Donna Neuberg; Kunal Patel; Andrew Lamb; Michael Andreeff; Zeev Estrov; Miloslav Beran; Michael Keating; Elihu Estey; Maher Albitar
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.
Leukemia research 2002;26(6):551-9.
2001: Yang O Huh; Michael J Keating; Helene Saffer; Iman Jilani; Susan Lerner; Maher Albitar
Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
American journal of clinical pathology 2001;116(3):437-43.
2001: S Ibrahim; Michael Keating; Kim-Anh Do; Susan O'Brien; Yang O Huh; Iman Jilani; Susan Lerner; Hagop M Kantarjian; Maher Albitar
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Blood 2001;98(1):181-6.